Clinical trials for Dedifferentiated liposarcoma
11 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT06498648Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue SarcomaNational Cancer Institute (NCI) · PI: Elise F Nassif
- RECRUITINGPhase 3NCT06422806Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasNational Cancer Institute (NCI) · PI: Seth M Pollack
- RECRUITINGPhase 2NCT06389799A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)Lund University Hospital
- RECRUITINGPhase 1NCT05711615Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaNational Cancer Institute (NCI) · PI: Candace L Haddox
- ACTIVE NOT RECRUITINGPhase 2NCT05694871Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated LiposarcomaAlliance for Clinical Trials in Oncology
- ACTIVE NOT RECRUITINGPhase 2NCT05886634A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated LiposarcomaMemorial Sloan Kettering Cancer Center · PI: Sandra D'Angelo, MD
- RECRUITINGPhase 1NCT05607095A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated LiposarcomaMemorial Sloan Kettering Cancer Center · PI: Alexander Shoushtari, MD
- ACTIVE NOT RECRUITINGPhase 3NCT04967521SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated LiposarcomaSarcoma Alliance for Research through Collaboration · PI: Mark Dickson, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04420975Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue SarcomaJonsson Comprehensive Cancer Center · PI: Vishruth Reddy, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT03114527Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Fox Chase Cancer Center · PI: Margaret von Mehren, MD
- ACTIVE NOT RECRUITINGPhase 2NCT02846987Study of Abemaciclib in Dedifferentiated LiposarcomaMemorial Sloan Kettering Cancer Center · PI: Mark Dickson, MD